Evidence map›Paper›PMID 40476522›Full record

ReviewAdvances in wound care2026

Clinical Measurement of Transepidermal Water Loss.

Dibyasankha Kundu, Anant Jayaraman, Chandan K Sen

Abstract readReview
In one paragraph

Review in Advances in wound care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Transepidermal water loss is positively correlated with blood pressure in young adults.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Article
  4. Article
  5. Skin examination in extreme conditions.Acta biochimica Polonica · 2026
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dibyasankha KunduDepartment of Surgery, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Anant JayaramanDepartment of Surgery, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Chandan K SenDepartment of Surgery, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-3151-5202

Funding

Diabetic Foot Ulcer Clinical Research UnitU01DK119099 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Gayle M Gordillo, Sashwati Roy · 2018 to 2026
$5.4M
Diabetic Foot Ulcer Biofilm Infection and RecurrenceR01DK125835 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GURTNER, GEOFFREY C, SEN, CHANDAN K · 2020 to 2024
$3.5M
Cell Specific Gene Editing to Close Diabetic WoundsR01DK135447 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Chandan K Sen · 2023 to 2026
$2.2M
Tissue reprogramming in diabetic wound healingR01DK128845 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROY, SASHWATI, SEN, CHANDAN K · 2021 to 2023
$1.5M
Vasculogenic Regenerative Medicine TechnologyR01DK141513 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Chandan K Sen · 2025 to 2026
$1.1M
NIDDK NIH HHS R01 DK125835NIDDK NIH HHS R01 DK128845NIDDK NIH HHS R01 DK135447NIDDK NIH HHS R01 DK141513NIDDK NIH HHS U01 DK119099
6 · The paper itself

Abstract

significanceRecent reports recognize transepidermal water loss (TEWL) as a critical objective parameter measuring clinical wound healing endpoint. At the site of wound repair, TEWL measures functional wound closure as marked by re-establishment of barrier function at the wound site. This review article addresses recent developments in clinical TEWL measurement in the context of human skin health and wound care. To that end, emphasis is placed on the review of registered clinical studies reported in ClinicalTrials.gov for which TEWL results have been posted or published. RECENT ADVANCES: The U.S. Food and Drug Administration (FDA) defines complete wound closure as the achievement of 100% re-epithelialization of the wound surface, with no detectable exudate, drainage, or need for wound dressing, as verified during two sequential clinical assessments conducted at least 14 days apart. Clinically, wounds may meet this current FDA-recommended clinical criteria for wound closure, yet not achieve functional wound closure which requires the re-establishment of barrier function at the site of repair. Such wounds are likely to recur. High TEWL posthealing predicts wound recurrence. Thus, TEWL measurement at the site of repair posthealing is emerging as a significant measurement of wound healing endpoint. CRITICAL ISSUES: Appropriate clinical measurement of TEWL requires a basic understanding of the related technologies and their appropriate use. Such understanding will help achieve the necessary rigor and reproducibility in clinical measurement. FUTURE DIRECTIONS: Recent reports on the critical significance of TEWL in wound care open new horizons wherein TEWL is likely to have broader applications involving altered skin barrier functions, such as during aging and other factors that determine skin health. Evidence to support revisiting the FDA definition of wound closure to include restoration of barrier function at the site of closure is strong. Widespread adoption of TEWL in wound care practices to determine functional wound closure is anticipated. [Figure: see text].

Indexed as

Water Loss, InsensibleWound HealingWounds and InjuriesHumansRe-EpithelializationSkinUnited Statesclinical trialsdeviceskin barrier functionTEWLtransepidermal water loss

Identifiers

PMID40476522
PMCPMC12359141

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.